跳至主要内容
临床试验/ACTRN12617001532392
ACTRN12617001532392尚未招募未知

To determine whether medical management including maintenance dialysis versus medical treatment alone reduces mortality and morbidity in highly co-morbid patients aged over 75 years with stage 5 chronic kidney disease,

The George Institute for Global Health0 个研究点目标入组 150 人开始时间: 2017年11月6日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
75 Years 至 o limit(—)
性别
All

入选标准

  • 1.Aged greater than or equal to 75 years
  • 2.With advanced chronic kidney disease, defined as having an eGFR of less than or equal to 12 ml/min/1.73m2
  • 3.Is expected by their treating physician to meet clinical criteria for entry to a maintenance dialysis program within the next 24 months.
  • 4.Has satisfied the treating unit’s policies relating to education regarding end stage kidney disease treatment options
  • 5.The treating physician caring for the participant has equipoise about the balance of risk and benefit for the participant should they enter either treatment arm of the study.

排除标准

  • 1.Treating physician considers it unlikely that the participant will adhere to allocated study treatment
  • 2.Participant unable to understand the implications of both of the study treatment arms for their future care
  • 3. The treating physician expects that the participant will not survive 3 months beyond study randomisation

研究者

相似试验